The Prostate Cancer Biorepository Network (PCBN)
Technical Report,30 Sep 2015,29 Sep 2016
WASHINGTON UNIV SEATTLE SEATTLE United States
Pagination or Media Count:
The Genitourinary Cancer Biorepository at the University of Washington joined the Prostate Cancer Pathology Resource Network PCBN September 30th 2014. The purpose of this interaction is to provide high quality, well annotated specimens that can be used by prostate cancer researchers through the PCBN. The University of Washington Biorepository has a focus on advanced stage disease. Specimens provided by the University of Washington site includes blood serum, plasma, and buffy coat, prostatectomy tissues frozen, biopsies and metastatic tissue from rapid autopsies paraffin embedded material and tissue microarrays TMAs, prostate cancer patient derived xenografts PDX and derived specimens DNA and RNA from prostate cancer patients. These specimens are linked to clinical and outcome data and supported by an informatics infrastructure. In this 2nd year of operation the University of Washington site has accrued new specimens from the clinic, surgery, and at autopsy, manufactured and provided TMAs, sera and derived RNA and DNA where required. Specimens were made available to prostate cancer researchers through the PCBN.